{"count": 5, "results": [{"_id": "32801686", "pmid": 32801686, "pmcid": "PMC7387832", "title": "Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin", "journal": "Int J Nanomedicine", "authors": ["Lu Z", "Qi L", "Lin YR", "Sun L", "Zhang L", "Wang GC", "Li JQ", "Yu JM"], "date": "2020-07-23T00:00:00Z", "doi": "10.2147/IJN.S253094", "meta_date_publication": "2020", "meta_volume": "15", "meta_issue": "", "meta_pages": "5203-5215", "score": 50268.16, "text_hl": "Thus, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is an ideal candidate to treat the @<m>DISEASE_Liver_Neoplasms</m> @DISEASE_MESH:D008113 @@@liver tumor@@@ with @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@.", "citations": {"NLM": "Lu Z, Qi L, Lin YR, Sun L, Zhang L, Wang GC, Li JQ, Yu JM. Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin Int J Nanomedicine. 2020;15():5203-5215. PMID: 32801686", "BibTeX": "@article{32801686, title={Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin}, author={Lu Z and Qi L and Lin YR and Sun L and Zhang L and Wang GC and Li JQ and Yu JM}, journal={Int J Nanomedicine}, volume={15}, pages={5203-5215}}"}}, {"_id": "35780231", "pmid": 35780231, "title": "Metformin inhibits the development and metastasis of colorectal cancer.", "journal": "Med Oncol", "authors": ["Sugiura K", "Okabayashi K", "Seishima R", "Ishida T", "Shigeta K", "Tsuruta M", "Hasegawa H", "Kitagawa Y"], "date": "2022-07-02T00:00:00Z", "doi": "10.1007/s12032-022-01722-y", "meta_date_publication": "2022 Jul 2", "meta_volume": "39", "meta_issue": "9", "meta_pages": "136", "score": 50250.395, "text_hl": "In @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancer@@@ xenograft @SPECIES_10090 @@@mice@@@, the @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver metastatic@@@ rate (10% vs. 50%, p = 0.05) and the number of @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver metastatic@@@ nodules (0.1/body vs. 1.2/body, p = 0.04) were significantly lower in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group. @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Tumor@@@ proliferation and EMT were decreased and apoptosis was promoted only in metastatic @<m>DISEASE_Liver_Neoplasms</m> @DISEASE_MESH:D008113 @@@liver tumors@@@ of @SPECIES_10090 @@@mice@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Sugiura K, Okabayashi K, Seishima R, Ishida T, Shigeta K, Tsuruta M, Hasegawa H, Kitagawa Y. Metformin inhibits the development and metastasis of colorectal cancer. Med Oncol. 2022 Jul 2;39(9):136. PMID: 35780231", "BibTeX": "@article{35780231, title={Metformin inhibits the development and metastasis of colorectal cancer.}, author={Sugiura K and Okabayashi K and Seishima R and Ishida T and Shigeta K and Tsuruta M and Hasegawa H and Kitagawa Y}, journal={Med Oncol}, volume={39}, number={9}, pages={136}}"}}, {"_id": "35378172", "pmid": 35378172, "title": "Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.", "journal": "J Hepatol", "authors": ["Wabitsch S", "McCallen JD", "Kamenyeva O", "Ruf B", "McVey JC", "Kabat J", "Walz JS", "Rotman Y", "Bauer KC", "Craig AJ", "Pouzolles M", "Phadke I", "Catania V", "Green BL", "Fu C", "Diggs LP", "Heinrich B", "Wang XW", "Ma C", "Greten TF"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.jhep.2022.03.010", "meta_date_publication": "2022 Sep", "meta_volume": "77", "meta_issue": "3", "meta_pages": "748-760", "score": 50243.746, "text_hl": "In vivo imaging analysis showed reduced motility of intratumoural CD8+ T cells. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment rescued the efficacy of anti-@GENE_PDCD1 @GENE_18566 @@@PD-1@@@ therapy against @<m>DISEASE_Liver_Neoplasms</m> @DISEASE_MESH:D008113 @@@liver tumours@@@ in @DISEASE_Fatty_Liver_Alcoholic @DISEASE_MESH:D005235 @@@NASH@@@. ", "citations": {"NLM": "Wabitsch S, McCallen JD, Kamenyeva O, Ruf B, McVey JC, Kabat J, Walz JS, Rotman Y, Bauer KC, Craig AJ, Pouzolles M, Phadke I, Catania V, Green BL, Fu C, Diggs LP, Heinrich B, Wang XW, Ma C, Greten TF. Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD. J Hepatol. 2022 Sep;77(3):748-760. PMID: 35378172", "BibTeX": "@article{35378172, title={Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.}, author={Wabitsch S and McCallen JD and Kamenyeva O and Ruf B and McVey JC and Kabat J and Walz JS and Rotman Y and Bauer KC and Craig AJ and Pouzolles M and Phadke I and Catania V and Green BL and Fu C and Diggs LP and Heinrich B and Wang XW and Ma C and Greten TF}, journal={J Hepatol}, volume={77}, number={3}, pages={748-760}}"}}, {"_id": "36433955", "pmid": 36433955, "pmcid": "PMC9700865", "title": "AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis", "journal": "Nat Commun", "authors": ["Wang Y", "Luo M", "Wang F", "Tong Y", "Li L", "Shu Y", "Qiao K", "Zhang L", "Yan G", "Liu J", "Ji H", "Xie Y", "Zhang Y", "Gao WQ", "Liu Y"], "date": "2022-11-24T00:00:00Z", "doi": "10.1038/s41467-022-34747-y", "meta_date_publication": "2022 Nov 24", "meta_volume": "13", "meta_issue": "1", "meta_pages": "7215", "score": 50227.914, "text_hl": "Importantly, @GENE_PROX1 @GENE_5629 @@@PROX1@@@ deficiency or @VARIANT_c.202G>T_TSC2_human @VARIANT_tmVar:p|Allele|S|79;VariantGroup:1;CorrespondingGene:7249;RS#:767626323;CorrespondingSpecies:9606 @@@Ser79@@@ phosphorylation in @<m>DISEASE_Liver_Neoplasms</m> @DISEASE_MESH:D008113 @@@liver tumour@@@ shows therapeutic resistance to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Wang Y, Luo M, Wang F, Tong Y, Li L, Shu Y, Qiao K, Zhang L, Yan G, Liu J, Ji H, Xie Y, Zhang Y, Gao WQ, Liu Y. AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis Nat Commun. 2022 Nov 24;13(1):7215. PMID: 36433955", "BibTeX": "@article{36433955, title={AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis}, author={Wang Y and Luo M and Wang F and Tong Y and Li L and Shu Y and Qiao K and Zhang L and Yan G and Liu J and Ji H and Xie Y and Zhang Y and Gao WQ and Liu Y}, journal={Nat Commun}, volume={13}, number={1}, pages={7215}}"}}, {"_id": "22467080", "pmid": 22467080, "title": "Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.", "journal": "Cancer Prev Res (Phila)", "authors": ["Bhalla K", "Hwang BJ", "Dewi RE", "Twaddel W", "Goloubeva OG", "Wong KK", "Saxena NK", "Biswal S", "Girnun GD"], "date": "2012-04-01T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-11-0228", "meta_date_publication": "2012 Apr", "meta_volume": "5", "meta_issue": "4", "meta_pages": "544-52", "score": 50050.88, "text_hl": "We show in these studies that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protected @SPECIES_10090 @@@mice@@@ against chemically induced @<m>DISEASE_Liver_Neoplasms</m> @DISEASE_MESH:D008113 @@@liver tumors@@@. ", "citations": {"NLM": "Bhalla K, Hwang BJ, Dewi RE, Twaddel W, Goloubeva OG, Wong KK, Saxena NK, Biswal S, Girnun GD. Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res (Phila). 2012 Apr;5(4):544-52. PMID: 22467080", "BibTeX": "@article{22467080, title={Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.}, author={Bhalla K and Hwang BJ and Dewi RE and Twaddel W and Goloubeva OG and Wong KK and Saxena NK and Biswal S and Girnun GD}, journal={Cancer Prev Res (Phila)}, volume={5}, number={4}, pages={544-52}}"}}]}